Additionally, PL was shown to inhibit the expression of c-Met through ROS-mediated proteasome independent pathway in RCC cells, which subsequently inhibited the phosphorylated levels of ERK1/2, STAT3, and Akt. Here, AKT1 is linked to renal cell carcinoma.